What Is Tirzepatide and How Does It Actually Work?
By Kaye Kohlmann, RN
If you've been hearing a lot about tirzepatide lately, you're not alone. It's one of the most talked-about weight loss medications on the market - and for good reason. But between the medical jargon, the social media hype, and the conflicting information online, it can be hard to know what's actually true. As an RN, I want to break it down in plain language.
First, a Little Biology
To understand tirzepatide, you need to know about two hormones your gut naturally releases when you eat: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). These are called "incretin" hormones, and their job is to tell your brain you're full, slow down digestion, and signal your pancreas to release insulin to manage blood sugar.
The problem for many people is that these signals don't work as efficiently as they should - especially in the context of obesity or metabolic dysfunction. That's where tirzepatide comes in.
What Makes Tirzepatide Different
Unlike semaglutide (Ozempic/Wegovy), which only targets GLP-1 receptors, tirzepatide is a dual agonist - it activates both GLP-1 and GIP receptors simultaneously. Think of it like turning up the volume on two hunger-suppressing signals at once instead of one.
This dual action means:
Stronger appetite regulation and reduced cravings
Better insulin response and blood sugar stability
Enhanced fat metabolism and overall metabolic performance
In clinical studies, this dual mechanism has shown impressive results - up to 20–26% total body weight reduction when combined with healthy lifestyle habits. That's meaningfully more than GLP-1-only therapies, which average around 15–17%.
How It's Actually Used
Tirzepatide is a once-weekly injectable. Through EllieMD's personalized program - which is what I connect my clients with - it's offered as a GLP-1/GIP injection, often combined with an additive like B12 or L-Carnitine to support energy and metabolism alongside the weight loss.
Treatment starts at a low dose and gradually increases over 12 weeks as your body adjusts. This titration approach minimizes side effects (more on that in a minute) and helps your provider find your personal "sweet spot" - the dose where you feel your best and see steady, sustainable results.
What to Expect
Most people don't see dramatic results in week one - and that's completely normal. The first few weeks are about letting your body adapt. You'll likely notice:
Reduced appetite and smaller portion sizes feeling more satisfying
Less interest in snacking or eating past fullness
Gradual, steady weight loss (a safe target is likely 1-2 lbs./week)
The most common side effects are GI-related - nausea, bloating, or loose stools - particularly as the dose increases. These typically improve as your body adjusts. Taking it on a consistent day each week, eating smaller meals, and staying hydrated all help.
Is It Right for You?
Tirzepatide isn't for everyone, and it does require a prescription through a licensed provider. Through EllieMD, you complete a medical intake, a board-certified physician reviews your history, and if you're a candidate, your personalized formula is dispensed from a licensed compounding pharmacy and shipped directly to you.
General eligibility starts at a BMI of 27+ with a qualifying health condition, or 30+ without one - though EllieMD's program also considers people with a BMI as low as 25 depending on your situation.
The Bottom Line
Tirzepatide works by doing what your body's own hormones are supposed to do - but doing it more effectively. For the right person, it can be a powerful tool in a larger wellness journey that includes nutrition, movement, and support.
As your EllieMD connection, I'm here to answer questions and help you figure out if this is the right path for you.
Disclaimer: This post is for informational purposes only and does not constitute medical advice. All EllieMD prescriptions are issued by licensed healthcare providers based on individual evaluation. Compounded medications are not FDA-approved.